TargetedOnc articles Copyright (c) 2009 Intellisphere, LLC. All rights reserved. http://www.targetedonc.com/articles TargetedOnc articles TargetedOnc articles en-us Wed, 01 Oct 2014 12:14:31 EDT 5 TargetedOnc articles 144 47 http://www.targetedonc.com/articles http://www.targetedonc.com/_media/_core/mainLogo.png <![CDATA[Outcomes Remain Similar Following 80405 RAS Analysis]]>http://www.targetedonc.com/conference/esmo-2014/Outcomes-Remain-Similar-Following-80405-RAS-AnalysisTargetedOnc articlesusWed, 01 Oct 2014 11:33:18 EDTTargetedOnc<![CDATA[Anamorelin Improves Body Mass, Appetite in Patients With Advanced Lung Cancer]]>http://www.targetedonc.com/conference/esmo-2014/Anamorelin-Improves-Body-Mass-Appetite-in-Patients-with-Advanced-Lung-CancerTargetedOnc articlesusMon, 29 Sep 2014 14:50:51 EDTTargetedOnc<![CDATA[Treatment Update: Unresectable Medullary Thyroid Cancer]]>http://www.targetedonc.com/publications/special-reports/2014/head-and-neck-cancers-issue2/Treatment-Update-Unresectable-Medullary-Thyroid-CancerTargetedOnc articlesusMon, 29 Sep 2014 12:52:51 EDTTargetedOnc<![CDATA[Afatinib Improves PFS in Advanced Head and Neck Cancer]]>http://www.targetedonc.com/conference/esmo-2014/Afatinib-Improves-PFS-in-Advanced-Head-and-Neck-CancerTargetedOnc articlesusMon, 29 Sep 2014 12:28:32 EDTTargetedOnc<![CDATA[Pembrolizumab Demonstrates Tumor Shrinkage in Patients With Advanced NSCLC]]>http://www.targetedonc.com/conference/esmo-2014/Pembrolizumab-Demonstrates-Tumor-Shrinkage-in-Patients-with-Advanced-NSCLCTargetedOnc articlesusMon, 29 Sep 2014 12:13:01 EDTTargetedOnc<![CDATA[Nivolumab Effective as Second-Line Treatment for Advanced Melanoma]]>http://www.targetedonc.com/conference/esmo-2014/Nivolumab-Effective-as-Second-Line-Treatment-for-Advanced-MelanomaTargetedOnc articlesusMon, 29 Sep 2014 12:01:48 EDTTargetedOnc<![CDATA[Dramatic OS Benefit Seen in CLEOPATRA Trial Update]]>http://www.targetedonc.com/conference/esmo-2014/Dramatic-OS-Benefit-Seen-in-CLEOPATRA-Trial-UpdateTargetedOnc articlesusMon, 29 Sep 2014 11:32:40 EDTTargetedOnc<![CDATA[Sequencing Sorafenib and Lenvatinib in Thyroid Cancer]]>http://www.targetedonc.com/publications/special-reports/2014/head-and-neck-cancers-issue2/Sequencing-Sorafenib-and-Lenvatinib-in-Thyroid-CancerTargetedOnc articlesusSat, 27 Sep 2014 13:41:51 EDTTargetedOnc<![CDATA[The Side Effects of Lenvatinib]]>http://www.targetedonc.com/publications/special-reports/2014/head-and-neck-cancers-issue2/The-Side-Effects-of-LenvatinibTargetedOnc articlesusSat, 27 Sep 2014 13:41:44 EDTTargetedOnc<![CDATA[Immune Checkpoint Inhibitors for Head and Neck Cancers]]>http://www.targetedonc.com/publications/special-reports/2014/head-and-neck-cancers-issue2/Immune-Checkpoint-Inhibitors-for-Head-and-Neck-CancersTargetedOnc articlesusSat, 27 Sep 2014 13:41:35 EDTTargetedOnc a Targeted Oncology